Hyper II DHA/EPA
Recalling firm: Healthmaxx Global Inc.
Why it was recalled
In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling: 1) product named on the label is not actual product contained; 2)ingredients listed are not actual ingredients contained.
The exact product
Hyper II DHA/EPA, 100 Count Softgels. Product labeling reads in part:"Hyper II DHA/EPA Refined Deep Sea Fish Oil 50% DHA - 30% EPA***Dietary Supplement 100 Softgels***6 65176 05274 3***Manufactured for:HealthMax Products Co. Altadena, CA 91001***".
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
Lot # F0202 UPC 6 65176 05274 3
| Type | Code / value | Context |
|---|---|---|
| UPC | 665176052743 | Lot # F0202 UPC 6 65176 05274 3 |
| lot | F0202 | Lot # F0202 UPC 6 65176 05274 3 |
Recall details
- Recall number
- F-1926-2013
- Event ID
- 65733
- FDA status
- Terminated
- Initiated
- Jun 10, 2013
- Reported
- Oct 2, 2013
- Classified
- Sep 24, 2013
- Terminated
- Nov 14, 2014
- Quantity
- 2863 bottles
- Location
- Hacienda Heights, CA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
CA, MD, and NY
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.